Anemia, Aplastic: all 348 studies
Page 4 of 4. Open to participants first (100), then studies with results posted, then the rest; newest registration first within each.
- Comparison of Cy-Atg vs Flu-Atg for the Conditioning Therapy in Allo-HCT for Adult Aplastic AnemiaStatus unknownNCT01145976Phase 3
- Reduced-Intensity Preparative Regimen for Allogeneic Stem Cell Transplantation in Patients With Severe Aplastic AnemiaWithdrawnNCT01129323Not applicable
- Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation for Patients With Aplastic AnemiaCompletedNCT01105273Phase 1/2
- Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With DapsoneCompletedNCT00993694
- Alemtuzumab and Low-Dose Cyclosporine in Treating Patients With Severe Aplastic Anemia or Acquired Marrow FailureStatus unknownNCT00895739Phase 2
- Reduced Toxicity Fludarabine (Flu) + Cyclophosphamide (CPM) + Rabbit Antithymocyte Globulin (rATG) Conditioning Regimen for Unrelated Donor Transplantation in Severe Aplastic Anemia (SAA)Status unknownNCT00882323Phase 2
- Study of Fludarabine + Cyclophosphamide + TBI Conditioning Regimen for Double Units Cord Blood Transplantation(CBT)in Severe Aplastic Anemia(SAA)Status unknownNCT00881933Phase 1/2
- Comparison of Cy-Atg Vs Cy-Flu-Atg for the Conditioning Therapy in Allo-HCTCompletedNCT00774527Phase 3
- Neuropsychological Effects of Immunosuppressive Treatment in Subjects With Aplastic AnemiaCompletedNCT00767650
- Flu+CPM+rATG Conditioning Regimes for Unrelated Bone Marrow Transplantation (UBMT)(or Mobilized Peripheral Blood)in Severe Aplastic Anemia (SAA)Status unknownNCT00737685Phase 2
- Unrelated Umbilical Cord Blood Transplantation Augmented With ALDHbr Umbilical Cord Blood CellsCompletedNCT00692926Phase 1
- Nonmyeloablative Allo SCT for the Treatment of Hematologic DisordersCompletedNCT00636909Phase 2
- Peripheral Blood Stem Cell Transplantation (PBSCT)From Haploidentical Related DonorsCompletedNCT00618969Phase 2
- Allogeneic Stem Cell Transplantation for Patients With Severe Aplastic AnemiaCompletedNCT00578266Phase 1
- Investigation of the Cylex® ImmuKnow® AssayCompletedNCT00569842
- Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treatment of Hematologic DisordersCompletedNCT00533923Phase 2
- Phase II Study Evaluating Busulfan and Fludarabine as Preparative Therapy in Adults With Hematopoietic Disorders Undergoing MUD SCTCompletedNCT00516152Phase 2
- Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic AnemiaCompletedNCT00513175
- Safety and Efficacy Study of Ex Vivo Immunotherapy for Treatment of Aplastic AnemiaStatus unknownNCT00399971Phase 1/2
- Cyclophosphamide, Antithymocyte Globulin, and Total-Body Irradiation in Treating Patients With Severe Aplastic Anemia Undergoing Umbilical Cord Blood TransplantTerminatedNCT00354419Phase 1
- Sirolimus and Cyclosporine for Treatment-Resistant Aplastic AnemiaStatus unknownNCT00319878Phase 1/2
- Identifying Characteristics of Bone Marrow Failure SyndromesStatus unknownNCT00315419
- Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic AnemiaStatus unknownNCT00295997Not applicable
- Oxandrolone for the Treatment of Bone Marrow Aplasia in Fanconi AnemiaCompletedNCT00243399Phase 1
- New York Blood Center National Cord Blood ProgramTerminatedNCT00212407Early Phase 1
- Purified CD34+ Hematopoietic Stem Cell Transplantation From Alternate Donors for Patients With Severe Aplastic AnemiaCompletedNCT00186797Not applicable
- Conditioning Regimens for Patients With Severe Aplastic Anemia Transplanted With Marrow From an Unrelated DonorCompletedNCT00144729Phase 1/2
- Study of Deferasirox in Iron Overload From Beta-thalassemia Unable to be Treated With Deferoxamine or Chronic AnemiasCompletedNCT00061763Phase 2
- Improving Immunosuppressive Treatment for Patients With Severe Aplastic AnemiaCompletedNCT00061360Phase 2
- Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic AnemiaCompletedNCT00054236Phase 1
- Collection of Biological Samples From Patients With Hepatitis-Associated Aplastic AnemiaCompletedNCT00050115
- Blood Transplantation for Patients With Hematologic Malignancies or Bone Marrow Failure StatesTerminatedNCT00038779Not applicable
- Study of Allogeneic Bone Marrow and T-Cell Depleted, CD34+ Peripheral Blood Stem Cell Transplantation in Patients With Aplastic AnemiaStatus unknownNCT00017654Not applicable
- Stem Cell Mobilization Potential in Patients With Aplastic Anemia in RemissionCompletedNCT00011830Phase 1
- Protection Against Benzene ToxicityCompletedNCT00011453
- Oral Manifestations of Aplastic AnemiaCompletedNCT00006300
- Mycophenolate Mofetil and Cyclosporine to Treat Relapsing Aplastic AnemiaCompletedNCT00005935Phase 2
- Aplastic Anemia Epidemiology: Incidence and Case-controlCompletedNCT00005682
- Etiology of Blood Dyscrasias: Analysis of the International Agranulocytosis and Aplastic Anemia Study DataCompletedNCT00005307
- Drug Etiology of Aplastic Anemia and Related DyscrasiasCompletedNCT00005302
- Phase III Randomized Study of Cyclophosphamide With or Without Antithymocyte Globulin Before Bone Marrow Transplantation in Patients With Aplastic AnemiaCompletedNCT00004474Phase 3
- Study of High Dose Cyclophosphamide in Patients With Severe Aplastic Anemia and Paroxysmal Nocturnal HemoglobinuriaCompletedNCT00004464Phase 2
- Phase II Study of Bone Marrow Transplantation Using Related Donors in Patients With Aplastic AnemiaCompletedNCT00004323Phase 2
- Combination Therapy of Severe Aplastic AnemiaCompletedNCT00001964Phase 2
- Comparing Therapies for the Treatment of Severe Aplastic AnemiaCompletedNCT00001626Phase 2
- Stem Cell Factor Medication for Aplastic AnemiaCompletedNCT00001398Phase 1
- Cord Blood Stem Cell Transplantation Study (COBLT)CompletedNCT00000603Phase 2
- Multi-Center Trial of Anti-Thymocyte Globulin in Treatment of Aplastic Anemia and Other Hematologic DisordersCompletedNCT00000597Phase 3